| Tag | Content |
|---|
EnhancerAtlas ID | HS018-01766 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr1:183554120-183554770 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL1 | MA0477.1 | chr1:183554488-183554499 | AGTGACTCATG | + | 6.14 | | IRF1 | MA0050.2 | chr1:183554183-183554204 | CTTCACTTCTACTTTCACTTC | + | 6.26 | | Myod1 | MA0499.1 | chr1:183554264-183554277 | AGCAACAGCTGCA | - | 6.64 | | RUNX1 | MA0002.2 | chr1:183554157-183554168 | GTCTGTGGTTT | + | 6.62 | | Zfx | MA0146.2 | chr1:183554520-183554534 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09658 | chr1:183544492-183564274 | CD14 | | SE_59031 | chr1:183554698-183564142 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I183585 | chr1 | 183554136 | 183554535 |
|
Enhancer Sequence | CAATCCCAGG CTCTCTTTCT CCCCAGATTG CCATTGTGTC TGTGGTTTTT CTTTTAGAAA 60
AGACTTCACT TCTACTTTCA CTTCTTCAGG TAACTAACTG CATCTACATC TTTAAGGTCC 120
TTTGAGCATC TTGTGGTTGC CCTTAGCAAC AGCTGCATAC ATGGGTTTTA CAGGCTCTGT 180
TTCTGACCAA ACCATAGGAT CAAAGCCTTT CAGGGTGGCA CAGGATCAGA GCCCAGCCCT 240
CTCTCTGATG TCTGGACATT GTCTACAACC TCCCTGCTGC TCCATCCACG CCCGGCCTCA 300
CCCTCACCCC ACCCACACCA TGCACAGATC ATTTTCACTG TCAGAAAGTT CTTTATTAGG 360
CTGGGCTCAG TGACTCATGC CTGTAATCCC AGTACTTTGG GAGGCCGAGG CGGGTGGATC 420
ACAAGGTCAG GAGTTCGAGA CCAGCGTGGC CAACATGGTG AAACCCTGTC TCTACTGAAA 480
AATACACAAA TTAGCTGGAC GTAGTGGCGG GCACCTGTAA TCCCAGCTAC TTGGGAGGCT 540
GAGGCAAGAG AATTGTTTGA ACGTGGAAGG CAGAGGTTGC AGTGAGCCGA GATCGCGCCA 600
CTGCACTCCA GCCTGGGTGA CAGGGCGAAA CTCCGTCTCA AAAAAAAAAA 650
|
